We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Craneware Plc | CRW | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -50.00 | -2.18% | 2,240.00 | 16:35:27 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2,275.00 | 2,250.00 | 2,275.00 | 2,240.00 | 2,290.00 |
| Industry Sector |
|---|
| SOFTWARE & COMPUTER SERVICES |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 04/03/2024 | Interim | GBP | 0.13 | 21/03/2024 | 22/03/2024 | 15/04/2024 |
| 05/09/2023 | Final | USD | 0.2 | 23/11/2023 | 24/11/2023 | 15/12/2023 |
| 06/03/2023 | Interim | GBP | 0.125 | 23/03/2023 | 24/03/2023 | 14/04/2023 |
| 20/09/2022 | Final | GBP | 0.155 | 24/11/2022 | 25/11/2022 | 16/12/2022 |
| 14/03/2022 | Interim | GBP | 0.125 | 24/03/2022 | 25/03/2022 | 14/04/2022 |
| 21/09/2021 | Final | GBP | 0.155 | 25/11/2021 | 26/11/2021 | 21/12/2021 |
| 01/03/2021 | Interim | GBP | 0.12 | 18/03/2021 | 19/03/2021 | 15/04/2021 |
| 21/09/2020 | Final | GBP | 0.15 | 19/11/2020 | 20/11/2020 | 15/12/2020 |
| 03/03/2020 | Interim | GBP | 0.115 | 19/03/2020 | 20/03/2020 | 16/04/2020 |
| 03/09/2019 | Final | GBP | 0.15 | 28/11/2019 | 29/11/2019 | 19/12/2019 |
| Top Posts |
|---|
Posted at 09/9/2023 07:19 by mammyoko Looking firm for a return to > £20? Some large volumes this week prior to and after results. Confident outlook from Neilson - post-covid problems abating enabling hospitals to start to consider investing to optimise spend.The dataset obtained by CRW would have huge potential value to a trade buyer. I could easily see this being bought in the next 12 months. Companies in this sector such as EMIS, INS and ERGO with structural growth opportunities all recently bid for. |
Posted at 15/2/2022 18:10 by km18 ...from last year....Company overview: Today’s company provides healthcare institutions with something crucial for the long-term prosperity of such entities – optimization of financial and operational performance. The firm argues that roughly $22 million in revenue are not captured from the average 350-bed hospital, and that is a lot even in the world of hyper expensive testing and analysis robots a modern hospital has. Craneware’s ambition is to reduce the foregone profits through its cycle experts and innovative technology which ensure transparency. They have 11 key products in their portfolio, which tackle different parts of the revenue generation cycle of each hospital. The company was founded in 1999 and currently has offices in UK and USA ad serves more than 1/3rd of the registered hospitals on US soil. The company is growing organically, without any big acquisitions during the past 10 years. Goodwill for the period ending June 2021 was at $11.1m, or 3% which is negligible. Growth in the fundamentals is strong, with revenue CAGR of 8.68% and EPS at 4.06%. Return on capital employed is growing at 25.5% on compound basis and net gearing is negative. Return on equity is in the top quartile of the industry at 7.9% and dividends are growing at 11.6% CAGR. Today they have released their final results for the FY 2021 (ending in June). Revenue swelled by 6% reaching $75.6m. PBT is below last year’s figures at $13.2m due to exceptional costs from the acquisition they did. As a result, EPS is down on 2020 figures to 48.1 cents. They have increased their expenditures on R&D and proposed an increase in dividends from 18.45 cents to 21.47 cents. Outlook is positive and momentum in sales is sustained in the new financial period. Management is “ confident in return to double digit organic growth”....fro |
Posted at 09/6/2021 08:07 by rimau1 The good news for private investors is that you can now buy below the placing price. High quality company and i am happy to buy back having exited last year. £21.50 and i will add more if it falls further, acquisition looks compelling given that only 33% of Sentry customers are existing CRW clients. Given high barriers to entry this is a huge cross selling opportunity. |
Posted at 08/6/2021 12:10 by jombaston They have shown scant regard for the principles of pre-emption and yet they have the nerve to put out this statement:"Craneware consulted with a number of its major shareholders prior to the Placing and has respected the principles of pre-emption through the allocation process. The Company is pleased by the support it has received from both existing and new shareholders." Of course, all the major shareholders knew this was coming hence the drift down in the share price. But not to save even a small amount for private investors is very disappointing especially for a 23% dilution. I might buy some more except I haven't seen or heard the presentation that the institutions have. Last year Diploma, a FTSE 250 member and much bigger company than CRW, made a 10% equity raise for an acquisition and gave shareholders a chance to buy through PrimaryBid. Why can't these guys do this? I agree it would be nice for all shareholders to be treated equally but shouldn't it be mandatory? |
Posted at 20/4/2021 21:28 by jonut Rush of blood to bonce yesterday when CRW broke through my upper trend line at £25.50.Broker wouldn't give an online quote so settled on a limit at 25.50. Ask was at 26 within 10 minutes. Disinclined to increase, I left it expecting CRW to carry on up.Close of business showed my limit accepted! Today the ask remained at £26 but the bid dropped to 24.50. Chanced a quote, to be bid 25.60 and took it. I should, of course be buying when the price falls through the bottom trend line but it does make you wonder what the MM's are playing at. Looking at the trades today, there are lots ~25.50 marked as buys. Nearly made a quid anyway. |
Posted at 21/9/2020 10:34 by jonut Full year figures today, much as expected.Slight nudge up in revenue/ebitda. Considering the customer loss last year and Covid this year, quite a reassuring set of numbers. the forward revenue figure of 200m over the next three years is a solid foundation for further progress. Added to my over weight position, heyho. |
Posted at 04/10/2019 23:40 by melody9999 Interesting vote of confidence from Keith Ashworth Lord in the latest Buffettology monthly fact sheet."Craneware was the standout performer, up 40.1% as the share price recovered from the drubbing it took in late June. In the intervening months, I had increased our share holding by over 14% having been satisfied that the company's recent travails would be short-lived." Well the share price has retraced since he wrote this, but he obviously has a positive view on CRW and future prospects. |
Posted at 18/6/2019 10:15 by sogoesit Thanks for the list Far Ting.I sometimes look at fund managers to get stock ideas. Glad I didn't get swayed by Woodford (albeit I have Burford). Dodged a bullet there. CRW currently at top of upward trend channel with CAGR of 65%. |
Posted at 07/6/2019 12:24 by thefartingcommie fyi...Woodford EIF...crw not listed here...(not much of equal quality!) ....maybe this list should be viewed with incredulity.. Name Industry % (weight) 1 Barratt Developments Consumer Goods 7.53 2 Burford Capital Financials 5.78 3 Taylor Wimpey Consumer Goods 5.37 4 Provident Financial Financials 4.81 5 Theravance Biopharma Health Care 4.71 6 Benevolent AI Technology 4.47 7 IP Group Financials 3.30 8 Countryside Properties Consumer Goods 3.13 9 Autolus Health Care 3.13 10 Oxford Nanopore Health Care 2.57 11 Imperial Brands Consumer Goods 2.36 12 Raven Property Convertible Pref 6.5% Financials 2.18 13 Stobart Industrials 2.14 14 BCA Marketplace Industrials 2.10 15 NewRiver REIT Financials 1.91 16 Purplebricks Financials 1.87 17 Honeycomb Investment Trust Financials 1.83 18 Eddie Stobart Logistics Industrials 1.72 19 Crest Nicholson Consumer Goods 1.72 20 Redde Financials 1.69 21 Industrial Heat Industrials 1.67 22 Oakley Capital Financials 1.59 23 Woodford Patient Capital Financials 1.56 24 Viamet Health Care 1.48 25 Prothena Health Care 1.46 26 Proton Partners International Health Care 1.46 27 Kier Industrials 1.42 28 Paypoint Industrials 1.26 29 Malin Financials 0.97 30 Arix Biosciences Financials 0.96 31 Sensyne Health Health Care 0.95 32 Immunocore A Health Care 0.93 33 Eurocell Industrials 0.87 34 Idex Technology 0.84 35 Watkin Jones Consumer Goods 0.81 36 Crystal Amber Fund Financials 0.77 37 Industrial Heat A1 Pref Industrials 0.73 38 Allied Minds Financials 0.71 39 Amigo Financials 0.71 40 Cequr Health Care 0.71 41 Benchmark Health Care 0.67 42 AA Industrials 0.66 43 Non-Standard Finance Financials 0.64 44 Card Factory Consumer Services 0.62 45 Evofem Biosciences Health Care 0.61 46 Raven Property Financials 0.60 47 Sabina Estates Pref 1 Financials 0.59 48 Sabina Estates Pref 4 Financials 0.59 49 Nucana Health Care 0.56 50 Horizon Discovery Health Care 0.56 51 Circassia Health Care 0.55 52 Time Out Consumer Services 0.51 53 Mercia Technologies Financials 0.50 54 Mereo Biopharma Health Care 0.50 55 Verseon Health Care 0.45 56 ReNeuron Health Care 0.44 57 Mafic Industrials 0.42 58 4D Pharma Health Care 0.39 59 AMO Pharma Health Care 0.38 60 Oxford Sciences Innovation Financials 0.34 61 Atom Bank Financials 0.33 62 Tissue Regenix Health Care 0.32 63 Ombu pref 1 Financials 0.30 64 Accelerated Digital Ventures A1 Financials 0.29 65 Kymab B Pref Health Care 0.21 66 RM2 International Industrials 0.20 67 Cambridge Innovation Capital Telecommunications 0.20 68 Sabina Estates Financials 0.20 69 Sabina Estates Pref 2 Financials 0.20 70 Sabina Estates Pref 3 Financials 0.20 71 Ombu Pref 8 Financials 0.17 72 Ombu Pref 9 Financials 0.17 73 Nexeon Industrials 0.17 74 Industrial Heat Industrials 0.16 75 Midatech Pharma Health Care 0.15 76 Ombu pref 2 Financials 0.13 77 Thin Film Electronics Industrials 0.11 78 Sabina Estates Pref 5 Financials 0.10 79 Mafic B Industrials 0.10 80 Verseon Health Care 0.10 81 Xeros Industrials 0.10 82 Viamet E Health Care 0.10 83 Immunocore Health Care 0.10 84 Northwest Biotherapeutics Health Care 0.10 85 Hvivo Health Care 0.09 86 Eve Sleep Consumer Goods 0.07 87 Kymab C Pref Health Care 0.07 88 Synairgen Health Care 0.07 89 Silence Therapeutics Health Care 0.07 90 Itaconix Basic Materials 0.06 91 Ombu pref 4 Financials 0.06 92 Brave Bison Technology 0.05 93 Safe Harbour Financials 0.05 94 Origin Health Care 0.05 95 Novabiotics Health Care 0.04 96 Metalysis Industrials 0.04 97 Industrial Heat Industrials 0.04 98 Netscientific Health Care 0.03 99 Nexeon Industrials 0.03 100 e-Therapeutics Health Care 0.03 101 Origin Pref Health Care 0.01 Quick links Download as PDF Download as Excel Fund facts Contribution analysis |
Posted at 05/3/2019 09:27 by thefartingcommie Craneware PLC CRW Peel Hunt Buy 2,465.00 2,660.00 2,800.00 3,505.00 Reiterates |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
